Treatment Results for Patients with Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study

Description

The objective of this study is to examine photos of CCCA patients taken before and after treatment to compare treatment outcomes between different treatment groups

Conditions

Central Centrifugal Cicatricial Alopecia (CCCA)

Talk to us

Study Overview

On this page

Study Details

Study overview

The objective of this study is to examine photos of CCCA patients taken before and after treatment to compare treatment outcomes between different treatment groups

Treatment Results for Patients with Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study

Treatment Results for Patients with Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study

Condition
Central Centrifugal Cicatricial Alopecia (CCCA)
Intervention / Treatment

-

Contacts and Locations

Winston-Salem

Wake Forest Baptist Health Department of Dermatology, Winston-Salem, North Carolina, United States, 27157

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * African-American women, ages 18-60 years old
  • * with a clinical diagnosis and biopsy-proven CCCA, with Central Scalp Alopecia Scale severity 1 through 4 will be included in this study
  • * These subjects will be seen and treated in Wake Forest Baptist Health Dermatology Outpatient Clinic
  • * Patients with other forms of hair loss in addition to CCCA will be excluded
  • * Other patients to be excluded are those with other forms of inflammatory scalp disease (with the exception of mild seborrheic dermatitis)
  • * patients who have had topical treatment for CCCA within the past 4 months (including topical steroids, topical minoxidil, or any other topical hair regrowth medication)
  • * patients who have been on a long-term oral antibiotics for hair loss within the past year
  • * patients who have undergone more than two rounds of intralesional steroid injections to the scalp in the past one year.

Ages Eligible for Study

18 Years to 60 Years

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

Wake Forest University Health Sciences,

Amy J McMichael, MD, PRINCIPAL_INVESTIGATOR, Wake Forest Baptist Health Department of Dermatology

Study Record Dates

2025-03